DeCurtis Corporation Receives Patent on a Method to Improve Fidelity and Reduce Traffic Incurred for Location Services
July 13, 2021 08:30 ET | DeCurtis Corporation
Orlando, Florida, July 13, 2021 (GLOBE NEWSWIRE) -- DeCurtis Corporation has been awarded a new patent titled "Beacon Reader with Reduced Network Data Traffic," once again improving...
CBondlogo-Red.png
C-Bond Systems Receives Notice of Allowance from U.S. Patent and Trademark Office for Seminal Glass Strengthening Patent
May 11, 2021 08:30 ET | C-Bond Systems
HOUSTON, May 11, 2021 (GLOBE NEWSWIRE) -- C-Bond Systems (the “Company” or “C-Bond”) (OTC: CBNT), a nanotechnology solutions company, announced today that it has received a notice of allowance from...
biomerica.png
Biomerica Reports 208% Increase In Q3 Fiscal 2021 Sales, Over Q3 Fiscal 2020
April 15, 2021 10:31 ET | Biomerica, Inc.
Sales increase driven by first sales of COVID-19 Antigen Rapid Test in Europe after January 2021 CE Mark approval Awarded two new patents for InFoods® diagnostic guided therapy technology, including...
Screen Shot 2020-07-28 at 11.27.29 AM.png
American BriVision Announces New Patent Filed for Treatment of Major Depressive Disorder
August 24, 2020 09:00 ET | American BriVision Holding Corporation
FREMONT, CA, Aug. 24, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE ‒ American BriVision (Holding) Corporation (OTCQB: ABVC) (the “Company”), a clinical-stage biopharmaceutical company developing...
biomerica.png
Biomerica Announces Notice of Allowance for New U.S. Patent Application Covering Diagnostic Guided Therapy for Irritable Bowel Syndrome (IBS)
April 08, 2019 08:19 ET | Biomerica, Inc.
IRVINE, Calif., April 08, 2019 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) announced today that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for...
ITL.jpg
ITL Pharma Receives United States Patent Protection for Carcinin® Using Halogenated Phenol Ethers for Diagnostics, Antioxidant Protection and Drug Delivery
November 26, 2018 08:00 ET | ITL Pharma, Inc.
KINGSPORT, Tenn., Nov. 26, 2018 (GLOBE NEWSWIRE) -- ITL Pharma, Inc. (ITL), a LIAS Company, today announced awarding of a United States Patent allowance (S.N. 15/336,179) titled: "Halogenated...
ABTLOGO.jpg
Advanced Biomedical Technologies Inc. Granted New Patent Strengthening its Core Technology
January 30, 2018 16:03 ET | Advanced Biomedical Technologies Inc
SHENZHEN, CHINA and NEW YORK, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Advanced Biomedical Technologies Inc. (OTCQB:ABMT), a developer and manufacturer of orthopaedic internal fixation devices, today...
BioAffinity.jpg
bioAffinity Technologies Announces Award of European Union Patent
May 03, 2017 14:00 ET | bioAffinity Technologies, Inc.
SAN ANTONIO, Texas, May 03, 2017 (GLOBE NEWSWIRE) -- bioAffinity Technologies announced that the European Patent Office (EPO) has issued a patent that protects the Company’s proprietary CyPath®...
ITL.jpg
ITL Pharma Receives United States Patent Protection for TriThroid® Using Sustained Drug Release and Improved Product Stability
February 14, 2017 09:10 ET | ITL Pharma, Inc.
KINGSPORT, Tenn., Feb. 14, 2017 (GLOBE NEWSWIRE) -- ITL Pharma, Inc. (ITL), a LIAS Research Company, today announced awarding of a United States Patent (US 9,526,701) titled: "Sustained Drug Release...
BioAffinity.jpg
bioAffinity Awarded New Patent; Company’s Patent Portfolio Continues to Expand
August 24, 2016 09:00 ET | bioAffinity Technologies, Inc.
SAN ANTONIO, Texas, Aug. 24, 2016 (GLOBE NEWSWIRE) -- bioAffinity Technologies today announced that it has been awarded a U.S. Patent protecting a proprietary kit that contains the...